Biotech companies are constantly furthering scientific advancement, treating diseases and contributing to the better health of all humans. As these
On Friday, a Director at CymaBay Therapeutics Inc (NASDAQ: CBAY), Carl Goldfischer, sold shares of CBAY for $128.1k. This is
Today, the EVP. Global Operations of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Julie O’Neill, sold shares of ALXN for $111.1k. In
There has been a lot of action on Wall Street today as analysts have weighed in on their favorite stocks.
Yesterday, a Major Shareholder at Calithera Biosciences Inc (NASDAQ: CALA), Adage Capital Partners Gp Llc, bought shares of CALA for
Today, the CEO & Chairman of Opko Health Inc (NYSE: OPK), Phillip Frost, bought shares of OPK for $172.9k. Over
Today, the CEO & Chairman of Opko Health Inc. (NYSE: OPK), Phillip Frost, bought shares of OPK for $98.62k. Over